Literature DB >> 221537

Kinetic model for production and metabolism of very low density lipoprotein triglycerides. Evidence for a slow production pathway and results for normolipidemic subjects.

L A Zech, S M Grundy, D Steinberg, M Berman.   

Abstract

A model for the synthesis and degradation of very low density lipoprotein triglyceride (VLDL-TG) in man is proposed to explain plasma VLDL-TG radioactivity data from studies conducted over a 48-h interval after injection of glycerol labeled with 14C, 3H, or both. The curve describing the radioactivity of plasma VLDL triglycerides reaches a maximum at about 2 h, after which the decay is biphasic in all cases; the late curvature becoming evident only after 8--12 h. To fit the complex curve, it was necessary to postulate two pathways for the incorporation of plasma glycerol into VLDL-TG, one much slower than the other. A process of stepwise delipidation of VLDL in the plasma compartment, previously proposed for VLDL apoprotein models, was also necessary. Predicted VLDL-TG synthesis rates calculated with this model can differ significantly from those based on experiments of shorter duration in which the slow VLDL-TG component is not apparent. The results of these studies strongly support the interpretation that the late, slow component of the VLDL-TG activity curve is predominantly due to the slowly turning-over precursor compartment in the conversion pathway and is not due either to a slow compartment in the labeled precursor, plasma free glycerol, or to an exchange of plasma VLDL-TG with an extravascular compartment. It also cannot, in these studies, be attributed to a slowly turning-over VLDL-TG moiety in the plasma. The model was tested with data from 59 studies including normal subjects and patients with obesity and(or) various forms of hyperlipoproteinemia. Good fits were obtained in all cases, and the estimated parameter values and their uncertainties for 13 normolipemic nonobese subjects are presented. Sensitivty testing was carried out to determine how critical various parameter estimations are to the assumptions introduced in the modeling.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221537      PMCID: PMC372075          DOI: 10.1172/JCI109421

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  VALIDATION OF AN INCOMPLETELY COUPLED TWO-COMPARTMENT NONRECYCLING CATENARY MODEL FOR TURNOVER OF LIVER AND PLASMA TRIGLYCERIDE IN MAN.

Authors:  J W FARQUHAR; R C GROSS; R M WAGNER; G M REAVEN
Journal:  J Lipid Res       Date:  1965-01       Impact factor: 5.922

2.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

3.  Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects.

Authors:  M Berman; M Hall; R I Levy; S Eisenberg; D W Bilheimer; R D Phair; R H Goebel
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

4.  Catabolism of very low density lipoprotein B apoprotein in man.

Authors:  M F Reardon; N H Fidge; P J Nestel
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

5.  Type III hyperlipoproteinemia: paradoxical hypolipidemic response to estrogen.

Authors:  R S Kushwaha; W R Hazzard; C Gagne; A Chait; J J Albers
Journal:  Ann Intern Med       Date:  1977-11       Impact factor: 25.391

6.  The metabolic heterogeneity of human very low density lipoprotein triglyceride.

Authors:  D Streja; M A Kallai; G Steiner
Journal:  Metabolism       Date:  1977-12       Impact factor: 8.694

7.  Endogenously labeled low density lipoprotein triglyceride and apoprotein B kinetics.

Authors:  C Malmendier; M Berman
Journal:  J Lipid Res       Date:  1978-11       Impact factor: 5.922

8.  Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia.

Authors:  S M Grundy; H Y Mok; L Zech; D Steinberg; M Berman
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

9.  Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia.

Authors:  A Pagnan; R J Havel; J P Kane; L Kotite
Journal:  J Lipid Res       Date:  1977-09       Impact factor: 5.922

10.  The passage of apoproteins from plasma lipoproteins into the lipoproteins of peripheral lymph in man.

Authors:  D Reichl; N B Myant; J J Pflug; D N Rudra
Journal:  Clin Sci Mol Med       Date:  1977-09
View more
  17 in total

1.  Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat.

Authors:  Chunyu Zheng; Katsunori Ikewaki; Brian W Walsh; Frank M Sacks
Journal:  J Lipid Res       Date:  2006-05-09       Impact factor: 5.922

2.  Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.

Authors:  H N Ginsberg; N A Le; J C Gibson
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

3.  Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.

Authors:  D E Wilson; M Emi; P H Iverius; A Hata; L L Wu; E Hillas; R R Williams; J M Lalouel
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

4.  Plasma triacylglycerol turnover in rats using labeled glycerol.

Authors:  N Baker
Journal:  Lipids       Date:  1984-02       Impact factor: 1.880

5.  Metabolic studies in an unusual case of asymptomatic familial hypobetalipoproteinemia with hypolphalipoproteinemia and fasting chylomicronemia.

Authors:  D Steinberg; S M Grundy; H Y Mok; J D Turner; D B Weinstein; W V Brown; J J Albers
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

6.  Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size.

Authors:  Daniël B van Schalkwijk; Albert A de Graaf; Ben van Ommen; Kees van Bochove; Patrick C N Rensen; Louis M Havekes; Niek C A van de Pas; Huub C J Hoefsloot; Jan van der Greef; Andreas P Freidig
Journal:  J Lipid Res       Date:  2009-06-10       Impact factor: 5.922

7.  Presence of very low density lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation.

Authors:  A Rivellese; G Riccardi; G Romano; R Giacco; L Patti; G Marotta; G Annuzzi; M Mancini
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

8.  Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease.

Authors:  Y A Kesäniemi; W F Beltz; S M Grundy
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

9.  Suppression by diets rich in fish oil of very low density lipoprotein production in man.

Authors:  P J Nestel; W E Connor; M F Reardon; S Connor; S Wong; R Boston
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

Review 10.  Fatty liver, insulin resistance, and dyslipidemia.

Authors:  Martin Adiels; Marja-Riitta Taskinen; Jan Borén
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.